Clinical Trials Browser

Phase 2 × OTHER_GOV × Lymphoma, B-Cell × Clear all

Addition of Nivolumab to Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive DLBCL at Lymphodepletion

Eltrombopag Treatment in Patients With Prolonged BM Toxicity After CART